The global atrial fibrillation surgery procedures market is expected to grow at a CAGR of 11.9% during the forecast period of 2015 to 2020. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the globe. According to American Heart Association, around 33.5 million people were suffering from atrial fibrillation around the world in 2013. Furthermore, about 200,000 to 400,000 new atrial fibrillation cases are diagnosed each year in the U.S.
This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation contributed to the maximum revenue in this market, in 2014. It will continue to hold dominant share in this market, growing at a CAGR of 14.5% during the forecast period of 2015 to 2020.
The geographical segmentation includes North America, Europe, Asia-Pacific and RoW. North America holds the largest share in this market, both in terms of the number of procedures and revenue. However, Asia-Pacific is expected to witness the highest growth rate due to the presence of a large patient population, increasing number of healthcare facilities, improving healthcare infrastructure, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India. Asia-Pacific atrial fibrillation catheter ablation market is expected to grow at a higher CAGR, compared to surgical ablation market, during the forecast period.
The key driver for this market is the increasing number of people suffering from atrial fibrillation. Favorable regulatory scenario would also propel growth in this market.
